Silexion Therapeutics (SLXN) Stock Chart & Stock Price History $0.84 -0.05 (-5.07%) Closing price 02/21/2025 03:56 PM EasternExtended Trading$0.80 -0.04 (-5.20%) As of 02/21/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends Silexion Therapeutics Stock Price Performance 5 Day Performance-21.77%1 Month Performance+13.91%3 Month Performance-69.42%Year-To-Date Performance-57.97% Receive SLXN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Silexion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address SLXN Stock Chart for Saturday, February, 22, 2025 SLXN Chart by TradingView Silexion Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025$0.89$0.84-5.07%$0.91$0.83438,846 shs$1.35 million02/20/2025$0.99$0.89-9.89%$1.00$0.84507,464 shs$1.42 million02/19/2025$1.03$0.99-4.11%$1.08$0.94771,274 shs$1.58 million02/18/2025$1.08$1.03-4.63%$1.19$1.03599,302 shs$1.65 million02/17/2025$1.08$1.08$1.28$1.021.58 million shs$1.73 million02/14/2025$1.27$1.08-14.96%$1.28$1.021.58 million shs$1.73 million02/13/2025$1.35$1.27-5.93%$1.35$1.25816,618 shs$2.03 million02/12/2025$1.38$1.35-2.17%$1.40$1.33567,782 shs$2.16 million02/11/2025$1.31$1.38+5.34%$1.44$1.252.48 million shs$2.21 million02/10/2025$1.26$1.31+3.97%$1.41$1.251.36 million shs$2.10 million Get the Latest News and Ratings for SLXN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Silexion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025$1.44$1.26-12.50%$1.45$1.261.36 million shs$2.02 million02/06/2025$1.37$1.44+5.11%$1.67$1.437.67 million shs$2.30 million02/05/2025$1.25$1.37+9.60%$1.74$1.209.09 million shs$2.00 million02/04/2025$1.57$1.25-20.38%$1.62$1.203.06 million shs$2 million02/03/2025$1.90$1.57-17.37%$1.73$1.552.27 million shs$2.51 million01/31/2025$2.05$1.90-7.32%$2.40$1.909.19 million shs$3.04 million01/30/2025$3.14$2.05-34.71%$2.30$1.8714.41 million shs$3.28 million01/29/2025$1.35$3.14+132.59%$3.45$1.84328.05 million shs$5.02 million01/28/2025$0.58$1.35+132.76%$1.56$1.00237.66 million shs$2.16 million01/27/2025$0.66$0.58-12.58%$0.65$0.58804,416 shs$928,000.0001/24/2025$0.66$0.66+0.82%$0.73$0.65718,047 shs$1.06 million01/23/2025$0.74$0.66-11.27%$0.76$0.651.79 million shs$1.05 million01/22/2025$0.77$0.74-3.68%$0.80$0.73547,921 shs$1.19 million01/21/2025$0.88$0.77-12.50%$0.86$0.752.00 million shs$1.23 million Related Companies RedHill Biopharma Stock Price Chart Galecto Stock Price Chart Aptorum Group Stock Price Chart Virax Biolabs Group Stock Price Chart Clearmind Medicine Stock Price Chart Soligenix Stock Price Chart Organovo Stock Price Chart ABVC BioPharma Stock Price Chart Alzamend Neuro Stock Price Chart Fresh Tracks Therapeutics Stock Price Chart Receive SLXN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Silexion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SLXN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silexion Therapeutics Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Silexion Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
